Seeing Is Believing

Currently out of the existing stock ratings of Jessica Fung, 1 are a SELL (4.76%), 10 are a HOLD (47.62%), 10 are a BUY (47.62%).
Analyst Jessica Fung, currently employed at JPMORGAN, carries an average stock price target met ratio of 100% that have a potential upside of 24.86% achieved within 541 days. Previously, Jessica Fung worked at GOLDMAN SACHS.
Jessica Fung’s has documented 40 price targets and ratings displayed on 4 stocks. The coverage is on Basic Materials, Healthcare sectors.
Most recent stock forecast was given on ALNY, Alnylam Pharmaceuticals at 13-Oct-2025.
Analyst best performing recommendations are on ALNY (ALNYLAM PHARMACEUTICALS).
The best stock recommendation documented was for ALNY (ALNYLAM PHARMACEUTICALS) at 8/26/2024. The price target of $280 was fulfilled within 1 day with a profit of $10.86 (4.04%) receiving and performance score of 40.35.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 01-Aug-2023
$69
$19.01 (38.03%)
$51
2 months 15 days ago
(09-Jul-2026)
5/6 (83.33%)
$24.88 (56.39%)
92
Buy Since 03-Apr-2023
$64
$18.55 (40.81%)
7 months 29 days ago
(26-Jan-2026)
12/12 (100%)
$-0.65 (-1.01%)
101
$55
$5.01 (10.02%)
$42
9 months 14 days ago
(10-Dec-2025)
5/5 (100%)
$6.47 (13.33%)
428
Buy Since 22-May-2024
$62
$16.55 (36.41%)
$46
11 months 14 days ago
(10-Oct-2025)
7/7 (100%)
$23.75 (62.09%)
325
Hold Since 12-Jul-2024
$23
1 years 5 months 9 days ago
(15-Apr-2025)
2/2 (100%)
$1.99 (9.47%)
11
What Year was the first public recommendation made by Jessica Fung?